| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| UNII: | 52G405U1E5 |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Ganglioside GM3 (NeuGcGM3) inhibitor | PubMed |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Carcinoma, Non-Small-Cell Lung | 3 | D002289 | ClinicalTrials |
| Neuroblastoma | 2 | D009447 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 946832-34-4 |
| ChEMBL | CHEMBL1743059 |
| FDA SRS | 52G405U1E5 |
| Guide to Pharmacology | 7995 |
CONTENTS